10x Genomics, Inc.

NASDAQ:TXG

9.42 (USD) • At close June 6, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2025 Q12024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q1
Revenue 154.883165.021151.654153.104141.006183.979153.644146.819134.285156.232131.072114.609114.496143.53125.297115.842105.821112.21871.81742.90571.90575.28961.20755.81953.57850.55436.60731.74429.576
Cost of Revenue 49.43854.06645.26146.20845.43777.91458.11547.20735.89536.82730.37727.70425.47827.59724.5184.91517.0618.89714.41110.05215.10816.58215.4815.00613.96514.95.2414.554.26
Gross Profit 105.445110.955106.393106.89695.569106.06595.52999.61298.39119.405100.69586.90589.018115.933100.779110.92788.76193.32157.40632.85356.79758.70745.72740.81339.61335.65431.36627.19425.316
Gross Profit Ratio 0.6810.6720.7020.6980.6780.5770.6220.6780.7330.7640.7680.7580.7770.8080.8040.9580.8390.8320.7990.7660.790.780.7470.7310.7390.7050.8570.8570.856
Reseach & Development Expenses 64.24566.96866.17462.91867.93855.55107.90971.4667.09863.61467.2970.68564.07861.88454.58253.40241.88339.70430.14327.53525.99227.88922.20918.03414.96513.0811.08511.44414.789
General & Administrative Expenses 0000082.82500075.18700065.17900054.07400037.25600026.206021.120.86
Selling & Marketing Expenses 000003.30003.70004.70001.90001.50000.700.10.1
SG&A 89.72893.82681.70483.03984.67486.12582.41591.5183.2878.88773.40179.33766.67569.87962.07668.70356.90455.97451.54944.41650.38738.75632.61432.57126.89326.90619.1121.220.96
Other Expenses 000-2.676-2.3553.961-1.248-1.504-1.5163.995-1.95-1.843-0.40.005-0.5990.521-0.7291.2160.361-0.144-0.0960.227-0.2720.005-0.146-0.098-0.03100
Operating Expenses 153.973160.794147.878148.633154.967141.675190.324162.97150.378142.501140.691150.022130.753131.763116.658122.10598.78795.67881.69271.95176.37966.64554.82350.60541.85839.98630.19532.80635.809
Operating Income -39.328-49.839-41.485-41.737-59.398-35.61-94.795-63.358-51.988-23.096-39.996-63.117-41.735-15.83-15.879-10.328-10.216-409.582-65.255-39.42-19.884-8.08-9.096-10.362-3.035-74.965-14.933-5.45-7.33
Operating Income Ratio -0.254-0.302-0.274-0.273-0.421-0.194-0.617-0.432-0.387-0.148-0.305-0.551-0.365-0.11-0.127-0.089-0.097-3.65-0.909-0.919-0.277-0.107-0.149-0.186-0.057-1.483-0.408-0.172-0.248
Total Other Income Expenses Net 5.8221.4597.0474.6581.595-10.9883.0512.5912.3346.685-0.039-0.7140.041-0.163-0.7690.37-0.90.96-0.008-0.325-0.9611.054-0.499-1.018-0.567-0.517-16.5-0.457-3.464
Income Before Tax -33.506-48.38-34.438-37.079-57.803-46.598-91.744-60.767-49.654-16.411-40.035-63.831-41.694-15.993-16.648-9.958-11.116-408.622-65.263-39.745-20.845-7.026-9.595-10.81-3.602-75.482-15.329-5.907-10.794
Income Before Tax Ratio -0.216-0.293-0.227-0.242-0.41-0.253-0.597-0.414-0.37-0.105-0.305-0.557-0.364-0.111-0.133-0.086-0.105-3.641-0.909-0.926-0.29-0.093-0.157-0.194-0.067-1.493-0.419-0.186-0.365
Income Tax Expense 0.8520.6481.3150.8182.1462.3541.2421.6471.0930.8041.8790.6270.7192.4560.5231.0940.4356.950.5850.4220.2980.1080.0080.0680.0340.0420.0160.0160.015
Net Income -34.358-49.028-35.753-37.897-59.949-48.952-92.986-62.414-50.747-17.215-41.914-64.458-42.413-18.449-17.171-11.052-11.551-415.572-65.848-40.167-21.143-7.134-9.603-10.878-3.636-75.524-15.345-5.923-10.808
Net Income Ratio -0.222-0.297-0.236-0.248-0.425-0.266-0.605-0.425-0.378-0.11-0.32-0.562-0.37-0.129-0.137-0.095-0.109-3.703-0.917-0.936-0.294-0.095-0.157-0.195-0.068-1.494-0.419-0.187-0.365
EPS -0.28-0.41-0.3-0.32-0.5-0.41-0.79-0.53-0.44-0.15-0.37-0.57-0.38-0.16-0.15-0.1-0.11-3.87-0.65-0.41-0.22-0.074-0.33-0.7-0.25-5.39-1.13-0.46-0.83
EPS Diluted -0.28-0.41-0.3-0.32-0.5-0.41-0.79-0.53-0.44-0.15-0.37-0.57-0.38-0.16-0.15-0.1-0.11-3.87-0.65-0.41-0.22-0.074-0.33-0.7-0.25-5.39-1.13-0.46-0.83
EBITDA -39.328-37.816-23.686-26.178-46.308-34.884-80.323-48.885-41.019-7.814-31.806-55.278-33.591-8.452-9.154-2.562-4.427-402.889-59.989-34.971-16.994-3.189-6.846-10.115-2.918-74.794-14.67-4.367-15.252
EBITDA Ratio -0.254-0.229-0.156-0.171-0.328-0.19-0.523-0.333-0.305-0.05-0.243-0.482-0.293-0.059-0.073-0.022-0.042-3.59-0.835-0.815-0.236-0.042-0.112-0.181-0.054-1.479-0.401-0.138-0.516